Literature DB >> 12021919

Colorectal de novo carcinoma: a review of its diagnosis, histopathology, molecular biology, and clinical relevance.

James D Mueller1, Birgit Bethke, Manfred Stolte.   

Abstract

The effort to reduce colorectal adenocarcinoma mortality increasingly depends on detection and removal of precancerous adenomas by colonoscopy. Sporadic reports have described small, aggressive carcinomas that do not appear to develop from adenomas and have been called "de novo" carcinomas. These lesions seem to challenge the basis of colorectal surveillance and are therefore a controversial topic. This review presents the history of the de novo concept, the problems concerned with the histopathologic diagnosis of these lesions and what is presently known about their clinical and molecular biologic features in comparison with the more common ex adenoma type of colorectal carcinomas. This information will show that, despite their rarity, it is important for both pathologists and gastroenterologists to be aware of these lesions.

Entities:  

Mesh:

Year:  2002        PMID: 12021919     DOI: 10.1007/s00428-002-0623-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  9 in total

1.  Depressed-type (0-IIc) colorectal neoplasm in patients with family history of first-degree relatives with colorectal cancer: A cross-sectional study.

Authors:  Junko Iwasaki; Yasushi Sano; Kuang-I Fu; Ai Machida; Tatsuya Okuno; Hikaru Kuwamura; Takayuki Yoshino; Kiyomi Mera; Shigeharu Kato; Atsushi Ohtsu; Shigeaki Yoshida; Takahiro Fujii
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

2.  Increased expression of beta-catenin, phosphorylated glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally spreading colorectal tumors.

Authors:  Jing Wang; Xinying Wang; Wei Gong; Biantao Mi; Side Liu; Bo Jiang
Journal:  J Histochem Cytochem       Date:  2008-12-08       Impact factor: 2.479

3.  Clinicopathological differences of colorectal cancers according to tumor origin: Identification of possibly de novo lesions.

Authors:  Petros C Papagiorgis; Adamantia E Zizi; Sophia Tseleni; Ioannis N Oikonomakis; Nikolaos I Nikiteas
Journal:  Biomed Rep       Date:  2012-10-09

4.  Gene expression profiling of laterally spreading tumors.

Authors:  Shoko Minemura; Takeshi Tanaka; Makoto Arai; Kenichiro Okimoto; Arata Oyamada; Keiko Saito; Daisuke Maruoka; Tomoaki Matsumura; Tomoo Nakagawa; Tatsuro Katsuno; Takashi Kishimoto; Osamu Yokosuka
Journal:  BMC Gastroenterol       Date:  2015-06-06       Impact factor: 3.067

5.  Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers.

Authors:  Ji Min Choi; Sang Gyun Kim; Jung Kim; Seung Jun Han; Jae Yong Park; Sooyeon Oh; Jong Pil Im; Joo Sung Kim; Woo Ho Kim; Hyun Chae Jung
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Characteristics of minute T1 colorectal cancer in relevance to pathology and treatment.

Authors:  Sin Hye Park; Seon Ok Oh; Sung Sil Park; Seung Jae Roh; Kyung Su Han; Bun Kim; Chang Won Hong; Byung Chang Kim; Dae Kyung Sohn; Hee Jin Chang; Sung Chan Park; Jae Hwan Oh
Journal:  Ann Surg Treat Res       Date:  2020-03-31       Impact factor: 1.859

7.  Solitary Rectal Ulcer Syndrome Is Not Always Ulcerated: A Case Report.

Authors:  Yi Liu; Zhihao Chen; Lizhou Dou; Zhaoyang Yang; Guiqi Wang
Journal:  Medicina (Kaunas)       Date:  2022-08-22       Impact factor: 2.948

8.  Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China.

Authors:  Yinan Ren; Mingye Zhao; Dachuang Zhou; Qian Xing; Fangfang Gong; Wenxi Tang
Journal:  Front Public Health       Date:  2022-08-12

9.  Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors.

Authors:  Tsubasa Saito; James K Chambers; Ko Nakashima; Kazumi Nibe; Koichi Ohno; Hajime Tsujimoto; Kazuyuki Uchida; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2020-07-13       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.